Evolent Health, Inc. reported results from its 2026 Annual Meeting, with shareholders electing ten directors and approving auditor ratification, executive compensation, and plan amendment.
Key takeaways
All ten director nominees were elected, with average votes for around 65 million shares.
Shareholders ratified Deloitte & Touche as auditor for FY2026 with 82,036,843 votes for.
Advisory vote on executive compensation passed with 58,369,473 votes for.
Amendment to incentive plan approved with 47,536,873 votes for despite 18,712,636 against.
Broker non-votes were significant at ~15.8 million for all proposals.